Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) S.A.E. Stock
Equities
RMDA
EGS381B1C015
Pharmaceuticals
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
2.22 EGP | -6.33% | -10.84% | +34.55% |
Sales 2024 * | 2.92B 60.98M | Sales 2025 * | 3.21B 67.15M | Capitalization | 3.31B 69.15M |
---|---|---|---|---|---|
Net income 2024 * | 361M 7.54M | Net income 2025 * | 485M 10.14M | EV / Sales 2024 * | 1.5 x |
Net Debt 2024 * | 1.07B 22.29M | Net Debt 2025 * | 766M 16.01M | EV / Sales 2025 * | 1.27 x |
P/E ratio 2024 * |
7.47
x | P/E ratio 2025 * |
6.8
x | Employees | - |
Yield 2024 * |
3.18% | Yield 2025 * |
4.79% | Free-Float | 50.28% |
1 day | -6.33% | ||
1 week | -10.84% | ||
Current month | -14.62% | ||
1 month | -22.92% | ||
3 months | +18.40% | ||
6 months | +41.40% | ||
Current year | +34.55% |
Managers | Title | Age | Since |
---|---|---|---|
Amr Morsy
CEO | Chief Executive Officer | - | 10-12-31 |
Mahmoud Fayek
DFI | Director of Finance/CFO | - | 18-12-31 |
Rania Farouk
CTO | Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Farida Khamis
BRD | Director/Board Member | - | 19-12-31 |
Director/Board Member | 65 | 18-12-31 | |
Director/Board Member | - | 10-12-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-24 | 2.22 | -6.33% | 13,400,680 |
24-04-23 | 2.37 | -5.58% | 5,209,276 |
24-04-22 | 2.51 | -1.18% | 4,664,347 |
24-04-21 | 2.54 | +2.01% | 3,522,580 |
24-04-18 | 2.49 | -4.60% | 8,651,035 |
End-of-day quote Egyptian Exchange, April 23, 2024
More quotesEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+34.55% | 69.08M | |
+25.44% | 556B | |
-6.33% | 354B | |
+19.90% | 331B | |
+7.95% | 296B | |
+13.13% | 233B | |
+5.23% | 201B | |
-10.14% | 193B | |
-12.26% | 143B | |
-6.47% | 144B |
- Stock Market
- Equities
- RMDA Stock